DeepCardio
PrivateLast Round
Series B
Feb 15, 2026
Total Funding Raised
$4.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DeepCardio operates in Healthcare & Life Sciences and is based in Incheon. Its latest recorded funding round was a Grant round in December 2025.
DeepCardio is a healthcare technology company that provides an AI-based solution to analyze ECG signals for the early prediction and detection of heart diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeepCardio Comparables
Compare DeepCardio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anumana | 81% | |
| Holmes AI | 79% | |
| Powerful Medical | 78% |
For institutional investors. Book with your work email.
DeepCardio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 15, 2026 | ||||
| Grant | Dec 8, 2025 | ||||
| Accelerator | Jul 17, 2025 | ||||
| Series A | Feb 17, 2022 |
For institutional investors. Book with your work email.
DeepCardio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DAYLI Partners | Series A |
| SoftBank Group | Series A |
| SBVA | Series A |
| Enlight Ventures | Series B |
| Government of South Korea | Grant |
| QUAD Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 15, 2026
$2.1M round raised
- Feb 15, 2026
Products used in over 20 major hospitals in Korea.
For institutional investors. Book with your work email.
DeepCardio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DeepCardio's valuation, stock price, and market status.
Is DeepCardio a public or private company?
DeepCardio is a private company.
What is the current stock price of DeepCardio?
DeepCardio is a private company, so its shares have no public market price. Caplight tracks DeepCardio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DeepCardio worth (valuation)?
Valuation information for DeepCardio is not publicly available.
Can I buy DeepCardio stock?
DeepCardio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DeepCardio's last funding round?
DeepCardio's most recent funding round was Series B on February 15, 2026.
Who are the main investors in DeepCardio?
Key investors in DeepCardio include DAYLI Partners, SoftBank Group, SBVA, Enlight Ventures, Government of South Korea.
Will DeepCardio IPO soon?
No public IPO plans have been announced for DeepCardio.
How can I track DeepCardio secondary market activity?
Caplight tracks bids, offers, and trades in DeepCardio's shares on secondary markets.